ACT 15774/2024

—·EP2697391B1

Verfahrensdetails: Status
—
Verfahrensart
Verletzung
Kategorie
Hauptverletzungsklage
Parteien: Kläger
10x Genomics, Inc.
Vertreter: Tilman Müller-Stoy (Bardehle Pagenberg); Martin Drews (Bardehle Pagenberg); Axel Berger (Bardehle Pagenberg)
Beklagte
Curio Bioscience Inc.
Vertreter: Agathe Michel-De Cazotte (Carpmaels & Ransford); Cameron Marshall (Carpmaels & Ransford); Christoph Höhne; Isabelle Schaller
Division: Dusseldorf LD
Richter: —
Technology: Biotech · Spatial Genomics
Sprache: —
Erste Entscheidung: 2. Mai 2025
Letzte Entscheidung: 16. Juni 2025

Entscheidungen

2025-05-02
Infringement Action
Interim procedure closure order in 10x Genomics, Inc. v. Curio Bioscience Inc. at Düsseldorf Local Division (EP 2 697 391 B1). Directions for the oral hearing were issued including: (1) translation of claim motions into English; (2) guidance on publication/media order requirements (Art. 80 UPCA); (3) clarification of 'such as' wording in supporting documents request; (4) parties to submit cost estimates (R. 104(k) RoP); (5) parties may upload hearing aids. Interim procedure closed.
Rechtsfragen:Closure of interim proceedings (R. 103, 104, 110.1 RoP)Requirements for publication order (Art. 80 UPCA)Format of motions and supporting documents

Dokumente